Genetics

AAV gene delivery vectors and cancer—The debate continues

Overwhelming evidence from the biomedical literature shows that adeno-associated virus 2 (AAV2), a viral vector often used to deliver therapeutic genes, is not associated with cancer and, in fact, may protect against cancer. ...

Genetics

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...

Diseases, Conditions, Syndromes

Global burden of dengue is triple current estimates

The global burden of dengue infection is more than triple current estimates from the World Health Organization, according to a multinational study published today in the journal Nature.

page 3 from 4